170 related articles for article (PubMed ID: 31656426)
1.
Jain H; Gada K; Zaidi S; Asiago-Reddy E; Eranki A
Proc (Bayl Univ Med Cent); 2019 Oct; 32(4):577-578. PubMed ID: 31656426
[TBL] [Abstract][Full Text] [Related]
2. A case of Pott's disease with epidural abscess and probable cerebral tuberculoma following Bacillus Calmette-Guérin therapy for superficial bladder cancer.
Josephson CB; Al-Azri S; Smyth DJ; Haase D; Johnston BL
Can J Infect Dis Med Microbiol; 2010; 21(1):e75-8. PubMed ID: 21358881
[TBL] [Abstract][Full Text] [Related]
3. A report of iliac muscle abscess due to Mycobacterium bovis after bacillus Calmette-Guerin therapy for bladder cancer.
Talluri SK; Marigowda L; Besur S; Talluri J; Forstall GJ
South Med J; 2010 Apr; 103(4):369-70. PubMed ID: 20224496
[TBL] [Abstract][Full Text] [Related]
4. Mycobacterium bovis Cerebellar Abscess Following Treatment With Bacillus Calmette-Guérin.
Sheron MW; Holt SL; Ingram CW
J Pharm Pract; 2017 Jun; 30(3):378-380. PubMed ID: 26966140
[TBL] [Abstract][Full Text] [Related]
5. A case of infectious thoracic aortic aneurysm after intravesical Bacillus Calmette-Guérin instillation therapy for a superficial bladder cancer.
Koterazawa S; Watanabe J; Uemura Y; Uegaki M; Shirahase T; Taki Y
Urol Case Rep; 2021 May; 36():101574. PubMed ID: 33552915
[TBL] [Abstract][Full Text] [Related]
6.
Meyer RK; Williams SJ; Lee TY
J Clin Tuberc Other Mycobact Dis; 2020 May; 19():100152. PubMed ID: 32140570
[TBL] [Abstract][Full Text] [Related]
7. Bacillus Calmette-Guérin strain differences as the basis for immunotherapies against bladder cancer.
Miyazaki J; Onozawa M; Takaoka E; Yano I
Int J Urol; 2018 May; 25(5):405-413. PubMed ID: 29506322
[TBL] [Abstract][Full Text] [Related]
8. Lumbosacral Vertebral Osteomyelitis With Iliopsoas and Epidural Abscess Following Intravesical Bacillus Calmette-Guérin Therapy.
Abbas AM; Bhandari J; Ngan A; Shahsavarani S; Verma RB
Cureus; 2023 Oct; 15(10):e47421. PubMed ID: 38021898
[TBL] [Abstract][Full Text] [Related]
9. Failed endovascular abdominal aortic aneurysm repair due to
Nishizawa M; Kudo T; Kijima T; Fujii Y
J Vasc Surg Cases Innov Tech; 2022 Dec; 8(4):807-812. PubMed ID: 36507086
[TBL] [Abstract][Full Text] [Related]
10. Abdominal aortic aneurysmal and endovascular device infection with iliopsoas abscess caused by Mycobacterium bovis as a complication of intravesical bacillus Calmette-Guérin therapy.
Mizoguchi H; Iida O; Dohi T; Tomoda K; Kimura H; Inoue K; Iwata T; Tei K; Miura T
Ann Vasc Surg; 2013 Nov; 27(8):1186.e1-5. PubMed ID: 23972639
[TBL] [Abstract][Full Text] [Related]
11. Mycotic aortic aneurysm due to intravesical BCG immunotherapy: Clinical manifestations and diagnostic challenges.
Holmes BJ; LaRue RW; Black JH; Dionne K; Parrish NM; Melia MT
Int J Mycobacteriol; 2014 Mar; 3(1):60-5. PubMed ID: 26786225
[TBL] [Abstract][Full Text] [Related]
12. Emerging Immunotherapy Options for bacillus Calmette-Guérin Unresponsive Nonmuscle Invasive Bladder Cancer.
Meng MV; Gschwend JE; Shore N; Grossfeld GD; Mostafid H; Black PC
J Urol; 2019 Dec; 202(6):1111-1119. PubMed ID: 31042108
[TBL] [Abstract][Full Text] [Related]
13. Killed but metabolically active Mycobacterium bovis bacillus Calmette-Guérin retains the antitumor ability of live bacillus Calmette-Guérin.
Secanella-Fandos S; Noguera-Ortega E; Olivares F; Luquin M; Julián E
J Urol; 2014 May; 191(5):1422-8. PubMed ID: 24333111
[TBL] [Abstract][Full Text] [Related]
14. Prosthetic Joint Infection due to Mycobacterium bovis after Intravesical Instillation of Bacillus Calmette-Guerin (BCG).
Gomez E; Chiang T; Louie T; Ponnapalli M; Eng R; Huang DB
Int J Microbiol; 2009; 2009():527208. PubMed ID: 20066167
[TBL] [Abstract][Full Text] [Related]
15. Disseminated Mycobacterium bovis Infection: A Rare Complication of Bacillus Calmette-Guérin Immunotherapy.
Henriques Mendes M; Guimarães A; Dahlstedt Ferreira C; Carneiro F; Santos L
Cureus; 2023 Dec; 15(12):e50407. PubMed ID: 38094875
[TBL] [Abstract][Full Text] [Related]
16. A rare case of vertebral osteomyelitis with associated epidural abscess complicating BCG immunotherapy for transitional cell carcinoma of the bladder.
Berneri M; Murray F; Davel S
IDCases; 2023; 32():e01773. PubMed ID: 37187939
[TBL] [Abstract][Full Text] [Related]
17. Systemic Bacillus Calmette-Guérin (BCG) Infection With Renal Involvement: A Rare Complication of BCG Immunotherapy.
Afonso R; Fontes J; Pinto P; Romano M; Esteves A
Cureus; 2022 Dec; 14(12):e33134. PubMed ID: 36726926
[TBL] [Abstract][Full Text] [Related]
18. Infection of an axillo-bifemoral bypass graft following intravesical bacillus Calmette-Guerin (BCG) immunotherapy for urothelial cancer due to
DeSimone DC; Tande AJ
J Clin Tuberc Other Mycobact Dis; 2016 Dec; 5():1-3. PubMed ID: 31723689
[TBL] [Abstract][Full Text] [Related]
19. A case of disseminated
Nishimura M; Okumura M; Takemasa T; Yoshiyama T; Tanaka Y; Saotome M; Ohta K
Respir Med Case Rep; 2023; 45():101902. PubMed ID: 37538979
[TBL] [Abstract][Full Text] [Related]
20. Pancreatic and psoas abscesses as a late complication of intravesical administration of bacillus Calmette-Guerin for bladder cancer: a case report and review of the literature.
Alvarez-Múgica M; Gómez JM; Vázquez VB; Monzón AJ; Rodríguez JM; Robles LR
J Med Case Rep; 2009 Sep; 3():7323. PubMed ID: 19918272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
